Health ❯Healthcare

Pharmaceuticals

Pharmaceuticals Public Health Clinical Trials Medical Research Pharmacology Patient Care Medical Treatments Drug Pricing Health Policy Corporate Finance

Obicetrapib Shows Promise in Reducing LDL Cholesterol and Lp(a) in High-Risk Patients

Phase 3 trial results reveal significant cholesterol reductions and a favorable safety profile, with a long-term outcomes study underway.

Trump Surgeon General Pick Casey Means Faces Bipartisan Scrutiny Over Credentials

Amazon Launches Online Pet Pharmacy in Partnership with Vetsource

Trump to Revive Medicare Drug Pricing Plan via Executive Order

Trump Administration NIH Cuts Terminate $1.81 Billion in Research Funding

HIV Drugs Linked to Reduced Alzheimer’s Risk in Landmark Study

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

Trump DOJ Defends FDA Abortion Pill Rules, Seeks Dismissal of State Lawsuit

WHO to Endorse GLP-1 Weight-Loss Drugs, Calls for Global Access

Eli Lilly Reports Record Q1 Revenue but Faces Profit Pressure and Competitive Challenges

Global Study Exposes Critical Antibiotic Access Gaps in Low- and Middle-Income Countries

Novo Nordisk Partners with Telehealth Firms to Expand Wegovy Access

New Study Reveals Abortion Pill Complication Rate 22 Times Higher Than FDA Estimate

LUT014 Gel Shows Promise in Reducing Severe Rash from Colorectal Cancer Therapy

Zongertinib Achieves Breakthrough in Treating HER2-Mutant Lung Cancer

Trump Administration’s Planned 25% Tariffs on Pharmaceuticals Expected to Raise U.S. Drug Costs by $51 Billion Annually

DEA Prepares for 28th National Prescription Drug Take Back Day on April 26

Federal Judge Upholds FDA Ban on Compounded Ozempic and Wegovy Copies

Bristol Myers Squibb Raises 2025 Forecast After Surpassing Q1 Expectations

Single-Dose Flu Drug Proven to Reduce Household Transmission by 30%